Skip to content

Céline VRANCKEN CPRE

Active
Private limited companyfounded 2022active for 4 yearsRue de Herve 609, 4030 Liège, BelgiumKBO/BCE: BE 0792.712.803
Summary

Céline VRANCKEN CPRE has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €86,729 and a net result of €27,287. Equity is growing by about 48% per year across the filed financial years. Its solvency ranks better than 45% of 1,243 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
Céline VRANCKEN CPREActiveChecked score 56/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€177,072total assets 2024
Equity
€86,729
Profit
€27,287
Financial health
56 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
0.2%
Structure
2025 accounts not filed, 87 days past the deadline1 deed in the Belgian Official Gazette
Why 56raises riskCapped at 59: a confirmed filing findingFigures for financial year 2024 (filed 22-08-2025)1 financial year not filed after the legal deadline; last filed accounts filed 22 days latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 4.17, cash €31,896Show the evidence

Checked score

Score 2024
56 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 53% of its sector peers (NACE 86, micro)
A confirmed filing finding caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2023
Strong
Solvency 74+23
equity 49.0% of total assets
Liquidity 72+6
short-term debt 10.3% · cash 18.0%
Profitability 88+3
return on assets 15.4%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.2%▲ +0.1 percentage points vs 09-2026highest value
Credit of up to €4,500 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance
Liquidity ample (current ratio 4.17, compared with 1.09 in 2023, above the usual 1.5; short-term debt: 10.3% and cash: 18% of total assets), but 51% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 39% on solvency, 53% on liquidity, 41% on profitability and 79% on growth.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Figures for financial year 2024 (filed 22-08-2025)
NBB · annual accounts
lowers risk · Liquidity: current ratio 4.17, cash €31,896
NBB · annual accounts
raises risk · 1 financial year not filed after the legal deadline; last filed accounts filed 22 days late
NBB · filings
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 87 days later.
NBB · 3 filings
Position against the passed deadline
31-12-2025 year end31-07-2026 deadline26-10-2026 today
raises risk · 2024 accounts filed 22 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 22-08-2025, 22 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 3 filings
Deviation from the deadline
2025
not filed
2024
22 days late
2023
26 days early
2022
16 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 4 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2022.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · full…
  2. Liquidity more than triplescurrent ratio 4.17
  3. Annual accounts filedfinancial year 2023 · full…

Key points

  • Caution: 2025 accounts not fileddeadline was 31-07-2026 87 days past the deadline View
  • Total assets 20243 financial years filed €177,072 View
  • Active since 2022founded 20-10-2022 4 years View

By topic

Financials

Financial year
2024
Total assets
€177,072
Profit
€27,287
Solvency
49.0%
Total assets▼ 23.4%
Net result
20222024
Go to Financials

Timeline

Events
6
Since
2023
  1. 31-12-2023Highest result from 2022 to 2024
  2. 31-12-2023Liquidity more than triples
  3. 16-08-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
20-10-2022
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Céline VRANCKEN CPRE

What is the company number of Céline VRANCKEN CPRE?
0792.712.803. In Belgium the VAT number is the company number with BE in front: BE 0792.712.803.
Where is Céline VRANCKEN CPRE based?
The registered office is at Rue de Herve 609, 4030 Liège.Company details
What does Céline VRANCKEN CPRE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Céline VRANCKEN CPRE?
Private limited company (BV).
When was Céline VRANCKEN CPRE founded?
On 20-10-2022.
Is Céline VRANCKEN CPRE still active?
Yes, Céline VRANCKEN CPRE is an active enterprise in the KBO register.
What is the turnover of Céline VRANCKEN CPRE?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Céline VRANCKEN CPRE profitable?
In financial year 2024, Céline VRANCKEN CPRE made a profit of €27,287.
Where can I find the annual accounts of Céline VRANCKEN CPRE?
Céline VRANCKEN CPRE filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2024.

Companies related to Céline VRANCKEN CPRE

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure